Business Standard

Kilitch Drugs (India) standalone net profit rises 92.22% in the December 2018 quarter

Image

Capital Market

Sales rise 48.12% to Rs 19.33 crore

Net profit of Kilitch Drugs (India) rose 92.22% to Rs 3.46 crore in the quarter ended December 2018 as against Rs 1.80 crore during the previous quarter ended December 2017. Sales rose 48.12% to Rs 19.33 crore in the quarter ended December 2018 as against Rs 13.05 crore during the previous quarter ended December 2017. ParticularsQuarter EndedDec. 2018Dec. 2017% Var.Sales19.3313.05 48 OPM %23.3316.70 -PBDT4.842.23 117 PBT4.531.93 135 NP3.461.80 92

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 13 2019 | 10:46 AM IST

Explore News